Future Healthcare of America

Certification of termination of registration of a class of securities (Section 12(g))

Withdrawal of a registration statement

Withdrawal of a registration statement

5.02

5.02

5.02

5.02

8.01,9.01

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

5.02,8.01

8.01

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

1.01,5.02,5.03,9.01

Prospectus Supplement with Pricing Information

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Correspondence with the SEC

Correspondence with the SEC

Amended Initial Registration Statement

3.03,9.01

Letter from the SEC

Registration (IPO) statement under Securities Act of 1933

5.02,9.01

8.01

8.01

5.02,9.01

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

1.01,8.01,9.01

1.01,5.02

1.01,3.02,5.02

3.02,3.03,9.01

1.03

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

1.01,3.02,5.03,9.01

Notification of late filing of Form 10-K

5.02

No description available

Definitive information statement

No description available

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

No description available

Prospectus Supplement with Pricing Information

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Registration (IPO) statement under Securities Act of 1933

General form for quarterly reports under Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Annual report pursuant to Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

NL Life Sciences BV

NL Life Sciences BV

SFI Gestion de Participaciones Minoritarias, S.L.U.

Groupe GFG Holding S.A. (Luxembourg)

Paladino Robert Alan

Efficiency Investment Fund - 6th Wave SP

GFG Monaco SAM

Zavaglia Stefano

Huisman Rudolf Derk

Huisman Rudolf Derk

Berkers Ellen

SPENCER CHRISTOPHER J

Busshaus John Lawrence

Busshaus John Lawrence

SPENCER CHRISTOPHER J